Idanis Berrios Morales to Multiple Sclerosis, Relapsing-Remitting
This is a "connection" page, showing publications Idanis Berrios Morales has written about Multiple Sclerosis, Relapsing-Remitting.
Connection Strength
0.206
-
Herman JA, Khalighinejad F, York K, Radu I, Berrios Morales I, Ionete C, Hemond CC. A real-world cohort analysis of alemtuzumab outcomes in relapsing multiple sclerosis. Mult Scler Relat Disord. 2021 Jan; 47:102619.
Score: 0.178
-
Cachia D, Izzy S, Berriosmorales I, Ionete C. Drug-induced thrombocytopenia secondary to natalizumab treatment. BMJ Case Rep. 2014 May 30; 2014.
Score: 0.028